Here are the biggest movers of the day:
Stock gainers:
Coherus BioSciences stock CHRS rose 17% as the Food and Drug Administration approved its treatment for nasopharyngeal cancer when combined with chemotherapy that it makes with Shanghai Junshi Biosciences.
Intuitive…
Read the full article here












